Knowledge, acceptability and personal attitude toward pre-implantation 1 genetic testing (PGT) and pre-natal diagnosis (PND) for females carrying BRCA pathogenic variant according to fertility preservation experience-Reference-Cited by-同舟云学术

Knowledge, acceptability and personal attitude toward pre-implantation 1 genetic testing (PGT) and pre-natal diagnosis (PND) for females carrying BRCA pathogenic variant according to fertility preservation experience

Published:2023-05-08 Issue:6 Volume:40 Page:1381-1390
ISSN:1058-0468
Container-title:Journal of Assisted Reproduction and Genetics
language:en
Short-container-title:J Assist Reprod Genet

Author:

Dervin Traicie,Ranisavjevic Noémie,Laot Lucie,Mayeur Anne,Duperier Constance,Steffann Julie,Borghese Roxana,Stoppa-Lyonnet Dominique,Frydman Nelly,Benachi Alexandra,Sonigo Charlotte^ORCID,Grynberg Michael

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Developmental Biology,Obstetrics and Gynecology,Genetics,Reproductive Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10815-023-02798-9.pdf

Reference26 articles.

1. Oktay K, Turan V, Titus S, Stobezki R, Liu L. BRCA mutations, DNA repair deficiency, and ovarian aging. Biol Reprod. 2015;93(3):67. https://doi.org/10.1095/biolreprod.115.132290.

2. Foulkes WD, Shuen AY. In Brief: BRCA1 and BRCA2. In Brief: BRCA1 and BRCA2. J Pathol. 2013;230:347–9.

3. Bedoschi G, Navarro PA, Oktay K. Chemotherapy-induced damage to ovary: mechanisms and clinical impact. Future Oncol. 2016;12:2333–44.

4. Valentini A, Finch A, Lubiński J, Byrski T, Ghadirian P, Kim-Sing C, et al. Chemotherapy-induced amenorrhea in patients with breast cancer with a BRCA1 or BRCA2 mutation. JCO. 2013;31:3914–9.

5. Hamy A-S, Porcher R, Cuvier C, Giacchetti S, Schlageter M-H, Coussieu C, et al. Ovarian reserve in breast cancer: assessment with anti-Müllerian hormone. Reprod Biomed Online. 2014;29:573–80.